Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Allergic Reactions02:06

Allergic Reactions

28.2K
Overview
28.2K
Antibody Structure01:10

Antibody Structure

61.0K
Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
61.0K
Allergic Drug Reactions01:27

Allergic Drug Reactions

936
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
936
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

404
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
404
Hypersensitivities01:30

Hypersensitivities

930
Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
930
Cross-reactivity00:42

Cross-reactivity

31.4K
Overview
31.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Allergic rhinitis in the elderly. In collaboration with ARIA guidelines.

The journal of allergy and clinical immunology. In practice·2026
Same author

Estimating Work-Related Indirect Costs in Allergic Rhinitis and Asthma Using a Daily Combined Symptom-Medication Score: A MASK-air Study in Collaboration With the EAACI Methodology Committee.

The journal of allergy and clinical immunology. In practice·2026
Same author

Polystyrene nanoplastics induce mitochondrial dysfunction and stress responses in human PBMCs.

Ecotoxicology and environmental safety·2026
Same author

Leveraging Artificial Intelligence in Allergy, Asthma, and Immunology With Environmental Exposures.

Allergy·2026
Same author

Treatment Dose Increase Versus Co-Medication in Allergic Rhinitis: Systematic Review With Dose-Response Network Meta-Analysis.

Allergy·2026
Same author

Meta-Analysis on the Harm of Systemic Glucocorticosteroids in Inflammatory Upper Airway Disease and Asthma: An EAACI Task Force.

Allergy·2026

Related Experiment Video

Updated: Aug 25, 2025

Humanized Mediator Release Assay as a Read-Out for Allergen Potency
10:22

Humanized Mediator Release Assay as a Read-Out for Allergen Potency

Published on: June 29, 2021

3.6K

Allergen immunotherapy: past, present and future.

Stephen R Durham1, Mohamed H Shamji2

  • 1Allergy and Clinical Immunology, National Heart and Lung Institute, Imperial College London, London, UK. s.durham@imperial.ac.uk.

Nature Reviews. Immunology
|October 17, 2022
PubMed
Summary
This summary is machine-generated.

Allergen immunotherapy, a therapeutic vaccination, offers long-term tolerance for IgE-mediated hypersensitivity. Novel strategies aim for safer, more effective treatments by exploring new routes and immune-modulating combinations.

More Related Videos

Basophil Activation Test for Allergy Diagnosis
07:22

Basophil Activation Test for Allergy Diagnosis

Published on: May 31, 2021

8.4K
Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber
08:47

Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber

Published on: March 3, 2023

2.5K

Related Experiment Videos

Last Updated: Aug 25, 2025

Humanized Mediator Release Assay as a Read-Out for Allergen Potency
10:22

Humanized Mediator Release Assay as a Read-Out for Allergen Potency

Published on: June 29, 2021

3.6K
Basophil Activation Test for Allergy Diagnosis
07:22

Basophil Activation Test for Allergy Diagnosis

Published on: May 31, 2021

8.4K
Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber
08:47

Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber

Published on: March 3, 2023

2.5K

Area of Science:

  • Immunology
  • Allergy and Clinical Immunology
  • Vaccinology

Background:

  • Allergen immunotherapy (AIT) is a treatment for IgE-mediated hypersensitivity to allergens like pollens, dust mites, and insect venom.
  • Established protocols involve subcutaneous injections or sublingual administration, inducing allergen-specific tolerance with long-lasting clinical benefits.
  • Oral immunotherapy can desensitize but does not induce long-term tolerance for conditions like peanut allergy.

Purpose of the Study:

  • To elucidate the immunological mechanisms underlying AIT-induced tolerance.
  • To explore novel strategies for developing safer, more effective, and convenient AIT regimens.
  • To achieve more durable long-term tolerance in patients with allergic hypersensitivities.

Main Methods:

  • Review of research and clinical trials on allergen immunotherapy.
  • Analysis of immunological mechanisms including T-cell responses and antibody production.
  • Exploration of novel therapeutic strategies such as alternative administration routes, adjuvants, recombinant allergens, and immune modifiers.

Main Results:

  • AIT induces tolerance by reducing allergen-specific T helper 2 (TH2) cells.
  • Mechanisms involve the induction of regulatory T and B cells and the production of blocking IgG and IgA antibodies.
  • Current research focuses on enhancing AIT efficacy and durability through innovative approaches.

Conclusions:

  • Allergen immunotherapy is a valuable treatment for allergic hypersensitivities, inducing specific tolerance through complex immunological mechanisms.
  • Ongoing research aims to optimize AIT by exploring new delivery methods, adjuvants, and targeted therapies.
  • Future directions focus on achieving sustained clinical benefit and improved patient outcomes through advanced immunotherapy strategies.